Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Download original image
Fig. 2. Improved rates in total gastroesophageal reflux disease symptoms after 4 and 8 weeks of medication (intention-to-treat analysis). E+M group, esomeprazole 40 mg once daily plus mosapride 5 mg 3 times daily for 8 weeks; E only group, esomeprazole 40 mg once daily plus placebo 5 mg 3 times daily for 8 weeks.
Journal of Neurogastroenterology and Motility 2017;23:218~228 https://doi.org/10.5056/jnm16100
© J Neurogastroenterol Motil